Prusha Patel

No ORCID on file · 5 papers in corpus
review 2024
Current oncology reports ·doi:10.1007/s11912-024-01595-6

PURPOSE OF REVIEW: This review aims to describe the association of integrating traditional Chinese medicine (TCM) herbs into conventional medicine (CM) in preventing breast cancer and improving survival rates among breast cancer patients of…

other 2018
The American journal of surgical pathology ·doi:10.1097/pas.0000000000001090

The International Endocervical Adenocarcinoma Criteria and Classification was developed to separate endocervical adenocarcinomas (ECAs) into 2 main categories on the basis of morphology such as human papilloma virus-associated (HPVA) and no…

other 2018
The American journal of surgical pathology ·doi:10.1097/pas.0000000000000986

We sought to classify endocervical adenocarcinomas (ECAs) based on morphologic features linked to etiology (ie, human papillomavirus [HPV] infection), unlike the World Health Organization 2014 classification. The International Endocervical …

observational 2018
Histopathology ·doi:10.1111/his.13444

AIMS: Evidence suggests that up to 70% of high-grade serous ovarian carcinomas (HGSCs) arise potentially from fallopian tube fimbriae, and that many of the remaining cases arise from within the ovary in cortical inclusion cysts (CICs) with …

observational 2017
International journal of cancer ·doi:10.1002/ijc.30910

Increasing parity and duration of combined oral contraceptive (COC) use provide substantial protection against ovarian carcinoma (cancer). There are limited data on the impact of the age of the births or age of COC use on reducing ovarian c…